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Abstract 
Introduction: Adolescent girls and young women (AGYW) remain disproportionately affected by HIV. In a rural 
area of South Africa with an annual incidence (2011–2015) of 5 and 7% per annum for 15–19 and 20–24-year olds 
respectively, oral pre-exposure prophylaxis (PrEP) could provide AGYW with a form of HIV prevention they can more 
easily control. Using quantitative and qualitative methods, we describe findings from a study conducted in 2017 
that assessed knowledge of and attitudes toward PrEP to better understand community readiness for an AGYW PrEP 
rollout.
Methods: We used descriptive analysis of a quantitative demographic survey (n = 8,414 ages 15–86) to identify pop-
ulation awareness and early PrEP adopters. We also conducted semi-structured, in-depth interviews with a purposive 
sample of 52 potential PrEP gatekeepers (health care workers, community leaders) to assess their potential influence 
in an AGYW PrEP rollout and describe the current sexual health landscape. Interviews were recorded, transcribed, and 
iteratively coded to identify major themes.
Results: PrEP knowledge in the general population, measured through a demographic survey, was low 
(n = 125/8,414, 1.49% had heard of the drug). Medicalized delivery pathways created hostility to AGYW PrEP use. 
Key informants had higher levels of knowledge about PrEP and saw it as a needed intervention. Community norms 
around adolescent sexuality, which painted sexually active youth as irresponsible and disengaged from their own 
health, made many ambivalent towards a PrEP rollout to AGYW. Health care workers discussed ways to shame AGYW 
if they tried to access PrEP as they feared the drug would encourage promiscuity and “risky” behaviour. Others inter-
viewed opposed provision on the basis of health care equity and feared PrEP would divert both drug and human 
resources from treatment programs.
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Introduction
Adolescent girls and young women (AGYW) (ages 
15–24) remain disproportionately affected by HIV, com-
prising 11% of the global population and 20% of new HIV 
diagnoses [1]. In sub-Saharan Africa (SSA), where 80% of 
AGYW living with HIV reside, AGYW become infected 
five to seven years earlier than their male counterparts 
[2, 3]. This increased vulnerability partially stems from 
sociodemographic and behavioural characteristics. Many 
AGYW in SSA are constrained in their ability to bargain 
for existing safer sex tools (i.e. condoms) given gendered 
cultural norms around sexual activity [4, 5]. Low socio-
economic status and diminished employment pros-
pects incentivize transactional sex, further diminishing 
AGYW’s bargaining capacities in sexual relationships [6, 
7].
Oral pre-exposure prophylaxis (PrEP) could help 
bridge the gender gap in prevention by offering AGYW 
an HIV prevention option they can more directly control 
than condoms. Daily oral regimens of antiretroviral drugs 
(ARVs) have proven effective at reducing the risk of HIV 
infection [8]. The World Health Organization (WHO) 
recommends PrEP be provided as part of a package of 
combination prevention options for groups at “sub-
stantial risk” of HIV (HIV incidence of approximately 
3 per 100 person years)[9]. The South African National 
Department of Health supports PrEP as part of combi-
nation prevention strategies [10] and the country began 
a targeted rollout to female sex workers (FSWs) in June 
2016 [11]. Efforts to make PrEP available to AGYW are 
underway [12].
Despite clinical effectiveness and policy maker enthu-
siasm, multiple randomized control trials of PrEP in 
AGYW in SSA have demonstrated low adherence to 
the drug and corresponding low efficacy [13, 14]. Open 
Label Extension trials (OLEs) in this population have 
shown higher levels of adherence than corresponding 
Randomised Controlled Trials (RCTs) [15]. While a PrEP 
rollout to AGYW in SSA is possible in well-resourced 
settings, broader support for potential and actual PrEP 
users and coordination of PrEP dissemination with exist-
ing clinical services will be critical [3, 16, 17].
Describing user, provider, and community views on 
and awareness of PrEP can help optimize PrEP provision 
to AGYW and facilitate scale-up by integrating new 
programs and tools with existing opportunities  [14, 
18–20]. Understanding such views and who holds them 
allows future PrEP provision programs to adapt to on-
the-ground realities, minimize friction with community 
beliefs and practices, and build support with potential 
gatekeepers to the drug. For example, achieving buy-in 
for AGYW PrEP provision from health care workers and 
other opinion leaders will be critical, given the biomedi-
calization of HIV prevention [21]. The shift in emphasis 
from controlling behaviours (i.e. using condoms) to con-
trolling bodies (i.e. supressing viral loads, using PrEP) 
means medical practitioners have the authority to decide 
which bodies are at significant enough risk to “deserve” 
care. These practitioners then continue to exercise 
authority by monitoring those receiving care. Such prac-
tices implicate previous social norms and relationships 
between providers and potential patients as critical fac-
ets of PrEP rollout [22, 23]. Biomedicalization also cedes 
substantial control to non-medical opinion leaders who 
might refer potential patients to providers.
Assessing current PrEP knowledge among community 
leaders, understanding their attitudes toward sexual and 
reproductive health services (SRHS) generally, and map-
ping ways to better target and retain potential users will 
be critical for a successful rollout in the north-east Kwa-
Zulu-Natal (KZN), a high HIV incidence area in rural 
South Africa. Unfortunately, little is known about aware-
ness of or attitudes toward PrEP in this area, especially 
among those who may provide it. Better understanding 
community leaders’ narratives about SRHS will aid future 
PrEP provision by showing how to reduce delivery bar-
riers and increase willingness to prescribe and support 
adherence to the drug.
The aim of this exploratory study was to understand the 
sexual health landscape for AGYW within which PrEP 
would be introduced in order to inform PrEP program-
ming for AGYW in rural KZN. Specifically, we describe 
awareness and uptake of PrEP within the wider com-
munity and explore attitudes towards AGYW accessing 
PrEP (in theory) and general SRHS (in current practice) 
amongst potential gatekeepers to the drug. We use this 
to elucidate potential challenges or facilitators to PrEP 
access among AGYW.
Conclusions: The health system in this poor, high-HIV incidence area had multiple barriers to a PrEP rollout to AGYW. 
Norms around adolescent sexuality and gatekeeper concerns that PrEP could divert health resources from treatment 
to prevention could create barriers to PrEP roll-out in this setting. Alternate modes of delivery, particularly those which 
are youth-led and demedicalize PrEP, must be explored.
Keywords: Pre-exposure prophylaxis (PrEP), Adolescents, Health system readiness, Sexual and reproductive health 
services
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Methods
Study design
This study was embedded within an implementation 
evaluation of the DREAMS Partnership in a rural, 
impoverished district in the north-east of KZN, South 
Africa. The area has an HIV incidence of > 5% per 
annum for AGYW. During 2017, when data collection 
for this study occurred, PrEP had only been provided 
in this area to FSWs through a single community-based 
organization funded by the DREAMS Partnership [24]. 
The DREAMS Partnership funded other evidence-
based practices targeted at the general population with 
the goal of decreasing rates of HIV in AGYW (e.g. cir-
cumcision for male partners, condom distribution, sex-
ual health education, cash grants to AGYW to continue 
school). Additional information about the DREAMS 
Partnership and the implementation evaluation at this 
field site has been described in other publications [24, 
25].
Throughout 2017, we used a mixture of demographic 
surveillance and key informant interviews to quantify the 
awareness and uptake of PrEP at the population level and 
describe the attitudes of potential gatekeepers to PrEP. 
Multiple data types were used to better contextualize 
the quantitative data as well as understand the environ-
ment in which future PrEP rollouts could occur, thus 
enabling barriers and facilitators to PrEP for AGYW to 
be identified.
Setting and population
The study area, a predominately rural region with high 
rates of poverty and unemployment, is in the Hlabisa sub-
district of the uMkhanyakude district in KZN [26]. HIV 
rates are persistently high with an antenatal prevalence 
of more than 40% [27]. The area hosts the Africa Health 
Research Institute (AHRI) (formally the Africa Centre for 
Health and Population Studies) which, since 2000, has 
used household-based surveys to collect demographic 
data from a population of approximately 100,000 indi-
viduals living in an area of 438  km2 within the district. 
AHRI surveys households three times per year to collect 
information on births, deaths, and migration patterns 
for all household members, including non-residents. 
Resident household members who were 15 years or older 
were invited to participate in annual, face-to-face, indi-
vidual surveys. For the duration of the DREAMS Part-
nership implementation evaluation, the Bill and Melinda 
Gates Foundation provided additional funding which 
allowed for the addition of a DREAMS-specific interview 
module to the demographic survey. This module meas-
ured PrEP awareness and uptake at a population level 
[25]. There was no PrEP provision in this area until 2016, 
when PrEP was rolled out to FSWs through the DREAMS 
Partnership.
Qualitative study
A purposive sample of 52 potential gatekeepers was 
assembled, including 10 people affiliated with the local 
Department of Education (DoE), 24 people affiliated with 
the local Department of Health (DoH), ten DREAMS 
stakeholders, four DREAMS evaluation fieldworkers, 
and four people affiliated with a local non-governmen-
tal organization providing PrEP to FSWs. Semi-struc-
tured, in-depth interviews were conducted from May to 
November 2017. Interviews lasted an hour on average 
and explored perceptions of the HIV epidemic in the 
area and its relation to adolescents, current awareness of 
PrEP and other novel biomedical HIV prevention tools, 
and attitudes toward PrEP provision, especially among 
AGYW.
Most interviews were conducted in isiZulu by research 
assistants (five females and four males) who had lived 
in the community for five to ten years and were familiar 
with community practices and norms. Fifteen of the DoH 
interviews and all field worker interviews were conducted 
by SEN, a female social scientist with prior PrEP research 
experience outside of South Africa. Interviews were 
recorded, transcribed verbatim, and translated to English 
if necessary. Interviewers also completed formal sum-
mary notes on the interviews which were shared among 
the research team to help shape future lines of inquiry. 
Interviews were coded iteratively. A unified codebook 
was created based on expected themes (from the inter-
view guide and formal summary notes) and emerging 
ones. Study team members both coded the same scripts 
and discussed emerging themes at multiple points dur-
ing the process to enhance validity. ATLAS.ti was used to 
store and manage the transcripts [28].
Quantitative analysis
Data from the AHRI’s demographic surveillance platform 
were used to explore PrEP knowledge. Information on 
sampling has been described in other publications [26]. 
Data were collected by teams of two trained fieldwork-
ers (age-sex matched where possible) visiting eligible 
individuals in their households. Fieldworkers conducted 
interviews with household members separately to main-
tain privacy and confidentiality. Population awareness 
and uptake of PrEP was quantified (mean and 95% confi-
dence interval) using the following questions: “Have you 
ever heard of PrEP? (These are tablets that people who 
do not have HIV can take to reduce the chances of catch-
ing HIV)” and “Are you currently taking PrEP to prevent 
HIV?”.
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To identify if there were any demographic details 
correlated with PrEP awareness and uptake, we strati-
fied awareness and uptake by gender and age band. We 
also stratified by previous engagement with HIV testing 
(measured through the question “Have you ever received 
a test result for HIV?). For female respondents only, we 
stratified by current and previous engagement with con-
traceptive services (measured through the questions “Are 
you currently using any contraceptive methods to prevent 
pregnancy?” and “In the past 12  months, have you used 
any method to avoid getting pregnant?”). Data cleaning, 
tabulation, and confidence interval calculations were per-
formed using Stata version 15 [29]. We did not perform 
any further tests for significance as there were low levels 
of awareness and uptake, and given the large sample size, 
there was a risk of finding spuriously significant associa-
tions [30].
Reflexivity statement
SEN is a white, North American researcher with past 
work disseminating PrEP to vulnerable populations in 
the US. The rest of the study team had prior experience 
working in the study area including MS, an HIV physician 
who has lived and worked with vulnerable populations in 
India, Burma, and South Africa, and JS, an anthropologist 
with extensive experience living and working in southern 
and eastern Africa. AHRI’s multi-decade engagement in 
this study area as well as the diverse perspectives of the 
study team strengthened study design, data collection 
and analysis.
Findings
Population awareness and uptake of PrEP
Of 13,562 eligible participants, 62.1% (n = 8,414) partici-
pated in the general health survey which contained ques-
tions related to PrEP. Within the subset of participants 
who answered the general health survey, 1.49% had heard 
of the drug (n = 125, 95% CI  1.23–1.74), Only one per-
son, a female between the ages of 25 and 34, reported 
using PrEP. Table  1 lists demographic details and PrEP 
awareness stratified by gender, age, history of HIV testing 
and current/previous contraceptive use.
Several themes emerged during the interviews to 
describe the reception of this area to AGYW PrEP roll-
outs. Figure 1 shows the interaction among these themes. 
Discussions with potential PrEP gatekeepers demon-
strated that future provision will likely be shaped by mul-
tiple factors. These factors include.
Table 1 Demographic characteristics
Variable N (%) PrEP awareness (N =) PrEP awareness 
% (95% CI)
Overall 8,414 (100%) 125 1.49 (1.23–1.74)
Female 6,129 (72.84%) 101 1.65 (1.33–1.97)
Male 2,285 (27.16%) 24 1.05 (0.63–1.47)
Age 15–19 1,523 (18.1%) 13 0.85 (0.39–1.32)
 20–24 1,045 (12.42%) 15 1.44 (0.71–2.16)
 25–34 1,648 (19.59%) 32 1.94 (1.28–2.61)
 35–44 1,117 (13.28%) 36 3.22 (2.19–4.26)
 Over 45 3,081(36.62%) 29 0.94 (0.60–1.28)
Current contraceptive use (female only) 1,048 (45.82%) 32 3.05 (2.01–4.10)
Past contraceptive use (female only) 1,023 (39.56%) 31 3.03 (1.98–4.08)
Previously tested for HIV 6,351 (76.11%) 106 1.67 (1.35–1.98)
Potential 
PrEP Landscape
Beliefs about
Youth Health
Health Care
Service Utilization
Perceived 
Barriers
Physical
Barriers
AYFS
Fig. 1 Interactions among emerging themes
Page 5 of 10Nakasone et al. AIDS Res Ther           (2020) 17:55  
• Existing beliefs about how youth choose to access 
services and which services providers believe they 
should be accessing,
• Existing barriers to youth accessing SRHS, and by
• Adolescent and youth friendly services (AYFS) that 
are currently being implemented at clinics.
Potential PrEP landscape
Participants were unaware of PrEP, or, if they had heard 
of it, were sceptical of its efficacy. For example, in dis-
cussions they shared “not knowing”, “not having an 
idea” about what PrEP was, and asked if PrEP “really 
worked”.
In contrast, local DoH employees had often heard of 
the pill through professional engagements and were more 
likely to trust its efficacy.
Once introduced to PrEP, many participants welcomed 
the availability of a new HIV prevention tool on principle. 
They couched this acceptance in terms of wider commu-
nity needs, usually appealing to high local rates of HIV. 
However, they also expressed significant concerns about 
introducing PrEP to AGYW. Participants believed that 
providing PrEP to adolescents would divorce the fear of 
HIV from sex and discourage condom use while encour-
aging sexual behaviour. As one DoH employee explained, 
“[giving adolescents PrEP] will mean setting them free to 
engage in unprotected sexual intercourse.”
Generally, participants did not name possible barriers 
to a PrEP rollout. The few they named matched problems 
that have characterized clinical trials of PrEP in AGYW 
(i.e. adolescents would not be able to remember to take 
a pill every day). Some worried clinic environments 
would discourage adolescents from seeking services, 
both because nurses would scold adolescents who sought 
SRHS and because wait times for services would be sub-
stantial. Few mentioned potential PrEP facilitators, but 
some referenced the possibility of using peer educators, 
providing adherence counselling, and dispensing PrEP 
at non-traditional sites, such as in schools and through 
mobile clinics. Others believed that nurses would be 
eager to help with a rollout to adolescents, given that it 
provided a way for them to protect “the future” of the 
country.
Beliefs about youth health
Participants often discussed their beliefs about adoles-
cent (often AGYW-specific) health beyond PrEP. Three 
major themes arose inductively from these reflections: 
moral anxiety about youth sexuality, guardianship, and 
concerns about equity.
Moral anxiety about youth sexuality
Participants often expressed significant concerns about 
the sexual health of the adolescents with whom they 
worked. While adolescent HIV infections worried many, 
participants spent more time discussing their fears about 
the high rates of other STIs and pregnancy. Elevated 
rates were attributed to a variety of influences, includ-
ing lack of condom use, disinterest in seeking treat-
ment, high substance abuse rates, and transactional sex 
relationships. Participants expressed a moral anxiety 
around a perceived existential crisis of adolescents’ “reck-
less” behaviour. From a field interviewer’s notes on an 
interview,
“[A DoH employee] said that the reason why young 
people are at risk is because they are attracted to 
things; they fail to learn from their mistakes.”
This judgement frequently emerged when discuss-
ing transactional sex relationships. Participants rarely 
discussed power imbalances within these relationships 
or the reliance on such relationships for economic sur-
vival and instead attributed this behaviour to AGYW’s 
desire for “nice stuff.” Participants often advocated for 
abstinence-only education, rationalizing that once youth 
became sexually active, they became impossible to con-
trol. As a DoE employee explained,
With regards to the issue of dating, [teachers] would 
say that [children] are now fine as they are now not 
dating anyone… [When the child stops dating], you 
see that the child is now a child, not that animal she 
has been, being uncontrollable.
Guardianship over adolescent sexuality
Given concerns for how youth conducted themselves and 
the perceived consequences of this conduct, participants, 
especially DoE and DoH employees, saw youth as una-
ble to determine their own health needs. As such, these 
participants believed that they (or their colleagues) were 
responsible for making sure that youth did the “right 
things.”
Generally, participants began by expressing how ado-
lescents were disengaged (either though lack of knowl-
edge or lack of care) from their own health. As one 
district stakeholder explained:
“Young people are special, and they don’t under-
stand other things well. They fail to take good deci-
sions towards other things.”
A nurse put it more bluntly:
“[Young women] have this ‘not care- don’t care’ atti-
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tude. Like, ‘I don’t care what happens to me tomor-
row.’”
To mitigate this perceived disinterest, participants 
described how they would make decisions on behalf of 
the adolescents with whom they interacted. Often, this 
took the form of performing unrequested STI/preg-
nancy tests when AGYW sought medical care. They also 
described how they or their colleagues strongly advised 
and even scolded AGYW who sought SRHS in the hopes 
that they could curb sexual behaviour. As a stakeholder 
explained:
“…nurses act as parents and if ever they are coming 
to just, you know, ask for contraceptives the nurse 
will just act as, you know, a guardian and tell the 
child that, ‘Why are you coming because you are 
not young, you’re not supposed to do this, you’re not 
supposed to take contraceptives,’ you know all those 
things.”
This intergenerational power dynamic may provide 
some benefit for an AGYW PrEP rollout. Some partici-
pants referenced the need to protect young women from 
HIV, given that they were the “future” of the country, as a 
motivator for becoming involved in PrEP work. The only 
nurse currently working on a PrEP rollout expressed this 
emotional draw to PrEP work, stating:
“… when I heard … about [PrEP], I said, ‘Let me go 
take a chance and see what happens because I want 
to see our community living.’ And when I heard them 
speaking about having treatment on trial to see if it 
can help prevent the community from being infected, 
I said, ‘No, I will not be left behind. Let me be one of 
the pioneers of that, so that my heart will be at peace 
and happy when I go home to retire, as I would have 
witnessed the job done.’”.
Concerns about equity
Some of the participants who were less stigmatizing of 
adolescents seeking SRHS noted the perceived unfair-
ness (and even short-sightedness) of focusing only on 
AGYW. This was especially true when participants dis-
cussed the DREAMS Partnership. The DREAMS Part-
nership provided the bulk of its services to AGYW, which 
participants believed alienated young men. Participants 
often noted that they were just as, if not more, concerned 
about the sexual health of adolescent boys and young 
men (ABYM) and similar sexual health resources, includ-
ing PrEP, should be offered to ABYM as well. As a DoE 
employee explained,
“You cannot fence your plants, but not cuff your 
goats. … What I mean is that DREAMS concen-
trates in girls and boys are not given that attention. 
They even ask me why they are not involved. Instead 
the attention is payed more to girls only. Girls do not 
get themselves pregnant, but a boy makes a girl. So, 
I think paying attention to girls is of much help, but 
they abandon boys who have an ability to impreg-
nate.”
Participants also worried about the “fairness “of provid-
ing PrEP generally. Many believed that the government 
lacked the resources to conduct such a rollout and wor-
ried that there would be a future time during which they 
would have to choose between providing ARVs for pre-
vention (through PrEP campaigns) and providing them 
for treatment (especially through the new guidelines 
that mandated starting ARVs when a patient first tested 
positive, regardless of CD4 count). Some DoH employees 
spoke of plans to ration PrEP to ensure they would always 
have enough ARVs for treatment. As one DoH employee 
explained,
“You look at the… drug stock outs, that we actually 
experience in our DoH clinics. The answer you’re 
going to get from a nurse in the clinic will be like, 
‘What happens when I’m out of drugs? So, why must 
I be giving PrEP instead of treating- trying to prevent 
the disease propagation in someone who’s already 
HIV positive?’ So, they’re going to think of it that 
way.”
Health care service utilization
Participants also described how adolescents interacted 
with health care services, generally noting that ado-
lescents eschewed clinic visits when possible. Some 
described the steps clinics were taking to attract AGYW 
and adolescents.
Perceived barriers
Participants cited three reasons for believing that ado-
lescents viewed clinics as places of stigma. First, DoH 
workers admitted that they or those they knew sought 
to dissuade adolescents (especially AGYW) from access-
ing SRHS. Some interviewed believed that through nag-
ging and scolding they could dissuade their patients from 
sexual activity. Participants acknowledged this behaviour 
often drove potential patients away. Second, participants 
believed adolescents avoided clinics for fear they would 
be seen there by their family or other community mem-
bers and face reprimands. As a DoE employee explained,
“Most [pregnant young women] come to the clinic 
when they are at an advanced stage. … They hide the 
pregnancy because of fear, and they tie the stomach 
with a belt. Their fear is that they will be seen at the 
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clinic standing in a queue waiting for an ultrasound, 
when they have not reported to their parents that 
they are pregnant.”
Third, participants sometimes discussed the district 
policy of sequestering HIV testing and treatment away 
from the main clinic in mobile trailers (“park homes”). 
This policy aimed to shorten waiting times for specific 
patients but, given the existing local stigma against peo-
ple living with HIV, instead discouraged adolescents from 
seeking HIV tests for fear that others would assume they 
were HIV positive. As a field worker explained,
“So now people will know that this section with park 
homes is for- it’s basically dealing with HIV related 
issues and then when you go to the main building, it’s 
for other, like for minor ailments and other diseases 
but when you go to park homes, it’s basically for HIV 
related issues. Now people are afraid of going to the 
clinic. Yeah. Because the setting is stigmatized.”
Physical barriers
Participants acknowledged that they often did not 
have the resources to attract adolescents. Understaff-
ing resulted in long lines that discouraged people from 
seeking care. The wait times were especially problem-
atic for school-aged adolescents who did not have the 
ability to wait at the clinic for long periods of time. Par-
ticipants also bemoaned the lack of funding to invest in 
more mobile and school-based outreach, which they 
believed would help them reach young people. As a DoH 
employee complained,
“So, there’s lack of stuff, there’s no stuff. Even the 
infrastructure at the clinics is not conducive enough 
to accommodate this youth friendly service, because 
you find that the clinic is, is maybe- maybe some of 
the clinics is having two consultation rooms. You 
can’t have now one that is now just going to be desig-
nated for the youth. … There are no resources, there 
is shortage of staff, the infrastructure is not condu-
cive. It’s just a pain, coming to work”.
Adolescent and Youth Friendly Services (AYFS)
In recognition of the barriers that adolescents gener-
ally faced when seeking care, many participants spoke 
about the new, district-wide push for AYFS. Participants 
explained that guidance from the local DoH recom-
mended clinics dedicate a separate room in which adoles-
cents could wait for services while watching TV, reading 
magazines, or otherwise entertaining themselves. Clin-
ics should also set up a “happy hour” time after school 
during which adolescents could be seen without delay 
and train at least one nurse to be a “youth friendly cham-
pion.” This nurse would ensure an adolescent-friendly, 
non-judgmental environment. Participants hoped these 
services would build rapport between clinics and adoles-
cents so that adolescents would feel comfortable seeking 
both health knowledge and treatment from clinics.
Participants noted that multiple barriers existed to 
implementing AYFS. Limited resources prevented alloca-
tion of youth-dedicated spaces or staff to run the “happy 
hour.” Frequent staff turnover often left the role of “youth 
friendly champion” vacant. The minimal training for peo-
ple who rotated through the position failed to change a 
culture of judgement against youth sexual activity. A 
DoH employee lamented the failed promise of AYFS by 
saying,
“There are other programmes that we implement at 
our clinics, like youth friendly, where we encourage 
the youth to come to the facilities even if they are not 
sick, just for information. Unfortunately, that project 
does not want to be fully operational.”
Discussion
In this rural setting with high rates of poverty and HIV 
incidence, we found that there were multiple barriers 
within the health system  to a PrEP rollout to AGYW, 
exacerbated by health care providers lack of prepared-
ness and existing norms around adolescent sexuality. 
While PrEP and other SRHS for AGYW ( e.g. long acting 
contraceptives) have been marketed as ways of increas-
ing empowerment and autonomy in young women, the 
biomedicalization of these services and their delivery 
removes power from the user and shifts it to the provider 
[31]. We found that within current delivery models, PrEP 
will remain embedded within existing biases and genera-
tional power relations, both real and perceived, which will 
harm a rollout through the health system. Community 
norms around adolescent sexuality expressed by poten-
tial PrEP gatekeepers showed that while many agreed an 
intervention like PrEP was needed in the abstract, they 
would be unwilling to facilitate AGYW PrEP access. This 
finding was especially pronounced among DoH staff 
who saw themselves as guardians of youth health and, 
more broadly, as arbiters of equitable access to health-
care. Many were (or believed their colleagues would be) 
reluctant to prescribe PrEP to AGYW for fear it would 
increase sexually risky behaviour and divert drugs from 
those living with HIV.
The lack of population-level PrEP awareness will 
likely heighten the gatekeeping dynamic between 
potential users and community leaders, particularly 
during the initial general PrEP rollout. DoH employ-
ees, especially, could have outsize power in choosing 
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to whom they recommend the drug and whom they 
discourage from using it, especially when low-levels 
of population knowledge prevent potential users from 
self-advocating and voicing the reasons why they would 
like to access PrEP [32, 33]. Similar gatekeeping dynam-
ics predicated on community norms around adolescent 
sexuality have been seen in past SRHS campaigns that 
used medicalized delivery pathways. In these situations, 
DoH employees who worried certain medical interven-
tions would encourage sexual activity in AGYW (e.g. 
contraception, termination of pregnancy services) 
succeeded in hindering and derailing previous roll-
outs [34–36]. Any PrEP rollout to AGYW in this area 
will benefit from substantial efforts to address existing 
norms around adolescent sexuality. Future research to 
develop and pilot PrEP training for gatekeepers to the 
drug that combats stated biases against SRHS provision 
to AGYW could be especially helpful.
We found that providing AYFS at clinics does not 
seems to be shifting norms around adolescent sexu-
ality. While some interviewed confirmed that many 
local clinics met standards for AYFS accreditation, 
judgement of adolescents accessing SRHS remained 
a major barrier to care. While this may have been the 
result of limited funding and high rates of staff turno-
ver, our finding matches earlier research showing that 
even when clinics can meet appropriate benchmarks 
for AYFS [37, 38], youth perceptions of care friendli-
ness barely improve [39]. This suggests that the cur-
rent structure of AYFS is inadequate for creating a 
welcoming, non-judgemental environment. Should 
PrEP be provided through clinics, the clinics in this 
area, (including those with existing AYFS) will require 
substantial changes in staffing and training to attract 
AGYW for PrEP.
Our findings offer a potential explanation for the failure 
of AYFS to change norms around adolescent sexuality. 
Medicalized delivery pathways, even those engineered for 
adolescents, reinforce existing power relationships and 
prioritize the intergenerational anxieties DoH employ-
ees have about adolescent sexuality. DoH employees saw 
their career as a means of guardianship for youth’s future 
health. Those interviewed believed that they and their 
colleagues had a moral responsibility to protect young 
women from engaging in sexual behaviour and thus a 
moral imperative to deny them PrEP because they feared 
prescribing PrEP would increase sexual activity, decrease 
condom use, and lead to more pregnancies and STIs. 
This framing of service denial as a moral issue by nurses 
in South Africa has been shown in relation to contracep-
tive services [35, 36, 40] but our research is some of the 
first in this area to expand this framing to PrEP and HIV 
prevention outside of condoms.
DoH employees’ view that their position had moral 
stakes extended beyond adolescent guardianship. DoH 
employees believed they had a moral imperative to 
ensure equitable access to health care. The introduc-
tion of a new drug in a health care setting those inter-
viewed believed to be resource impoverished worried 
many. Some DoH employees began to categorize those 
who might seek ARVs as either deserving (those who 
were using them for treatment) or undeserving (those 
who were using them for prevention). While the division 
of “deserving v. undeserving” [41] has been explored in 
gatekeeping dynamics, it has been rarely explored in the 
context of treatment and prevention. Previous work, in 
contrast, has shown that in past drug rationing, South 
African nurses were more likely to see people living with 
HIV as undeserving of care [20].
While some interviewed demonstrated that the moral 
imperatives by which DoH employees characterised their 
work could be used as an entry point to PrEP provision 
(i.e. through impressing upon HCWs that PrEP was a 
way to protect AGYW), it was not clear that this would 
work for a significant number of potential PrEP pro-
viders. Additionally, medicalized pathways, even those 
which profess AGYW empowerment, defer to medical 
providers and institutions that have been hostile to SRHS 
provision to AGYW. Future studies should explore the 
potential of demedicalizing PrEP and of using alternate 
modes of community-led or even youth-led delivery [42]. 
Such modes of delivery may help increase access and 
adherence to PrEP [43, 44]. They may also create new 
norms around adolescent sexuality and better combat 
stigma than current modes of delivery [45, 46].
Limitations
While our study contributes important findings to sup-
port South African efforts to provide PrEP to AGYW, 
we acknowledge its limitations. All interviews and sur-
vey responses were collected in a rural area of KZN. The 
results may not be generalizable to other areas of South 
Africa even though they provide important contextual 
information about similar areas with high HIV incidence. 
The quantitative data that measured the current popu-
lation awareness of oral PrEP was collected as part of a 
multi-hour longitudinal survey. Survey fatigue may have 
incorrectly skewed answers. The incredibly low level of 
PrEP knowledge still suggests that even with some skew, 
consciousness raising around PrEP will be essential in 
this area. Qualitative interviews were conducted before 
PrEP was available for any segment of the general popu-
lation. The opinions respondents stated were based on 
an abstract idea of what oral PrEP may do when intro-
duced to the community. These opinions may change in 
a general population PrEP rollout. Opinions may have 
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also changed after the interview: for some participants, 
this was their first introduction to the idea of ARV-based 
HIV prophylaxis and their views could have evolved with 
further reflection. Finally, respondents may have believed 
they needed to profess more excitement about PrEP and/
or hide concerns about the drug or its potential rollout 
to please the interviewer(s). Given the range of opinions; 
however, significant discordance between their personal 
beliefs and those professed during interviews is unlikely.
Conclusion
The health care system in this area of rural South Africa 
was unprepared to support a rollout of PrEP to AGYW. 
Community norms around adolescent sexuality, clinic 
environments that were ambivalent to AGYW seeking 
SRHS, and the moral conviction of some DoH employ-
ees who believed that PrEP provision would harm com-
munity members have the potential to adversely affect a 
PrEP rollout to AGYW. With current modes of delivery, 
PrEP rollouts may not offer the empowerment and sexual 
autonomy advertised for young women. Future research 
must investigate alternate modes of delivery, especially 
those that demedicalize PrEP and provide more opportu-
nities for community and youth leadership in its delivery.
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